483 CMIC CMO USA May 2018

483 CMIC CMO USA May 2018

Frederick Razzaghi FDA$119.00 - Available Now

FDA investigators audited the CMIC CMO USA - Cranbury, NJ, United States facility and issued inspectional observations (via FDA 483) on 08 May 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 08 May 2018
  • Location: Cranbury, United States
  • FEI: 3001237056
Add To Cart